BeOne Medicines Ltd.
ONC
58 insider filings · Latest: Oct 13, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 23, 2026 | Jun 23 8:13 PM | JOHN OYLER | Proposed Sale | 3,410 | $273.78 | $933.6K | — | View → |
| Jun 16, 2026 | Jun 18 9:19 PM | Xiaobin WuPresident and COO | Sale | 1,357 | $266.76 | $362.0K | 0(D) | View → |
| Jun 16, 2026 | Jun 18 9:19 PM | John OylerDirector, Chief Executive Officer | Sale | 3,693 | $265.55 | $980.7K | 0(D) | View → |
| Jun 16, 2026 | Jun 18 9:19 PM | Chan Henry LeeSVP, General Counsel | Sale | 590 | $265.98 | $156.9K | 0(D) | View → |
| Jun 16, 2026 | Jun 18 9:19 PM | Lai WangPresident, Global Head of R&D | Sale | 1,169 | $265.39 | $310.2K | 0(D) | View → |
| Jun 16, 2026 | Jun 16 8:15 PM | CHAN LEE | Proposed Sale | 590 | $265.98 | $156.9K | — | View → |
| Jun 16, 2026 | Jun 16 8:14 PM | LAI WANG | Proposed Sale | 1,169 | $265.39 | $310.2K | — | View → |
| Jun 16, 2026 | Jun 16 8:12 PM | XIAOBIN WU | Proposed Sale | 1,357 | $266.76 | $362.0K | — | View → |
| Jun 16, 2026 | Jun 16 8:11 PM | JOHN OYLER | Proposed Sale | 3,693 | $265.55 | $980.7K | — | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Titus B. BallPrincipal Accounting Officer | Sale | 169 | $257.20 | $43.5K | 0(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Lai WangPresident, Global Head of R&D | Sale | 756 | $261.00 | $197.3K | 0(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Aaron RosenbergChief Financial Officer | Sale | 631 | $257.74 | $162.6K | 0(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Xiaobin WuPresident and COO | Sale | 626 | $261.20 | $163.5K | 0(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Chan Henry LeeSVP, General Counsel | Sale | 428 | $257.64 | $110.3K | 0(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | John OylerDirector, Chief Executive Officer | Sale | 1,949 | $257.24 | $501.4K | 0(D) | View → |
| Jun 15, 2026 | Jun 15 8:21 PM | CORAZON D. SANDERS | Proposed Sale | 945 | $265.50 | $250.9K | — | View → |
| Jun 11, 2026 | Jun 11 8:32 PM | XIAOBIN WU | Proposed Sale | 626 | $261.20 | $163.5K | — | View → |
| Jun 11, 2026 | Jun 11 8:29 PM | LAI WANG | Proposed Sale | 756 | $261.42 | $197.6K | — | View → |
| Jun 11, 2026 | Jun 11 8:25 PM | AARON ROSENBERG | Proposed Sale | 631 | $257.74 | $162.6K | — | View → |
| Jun 11, 2026 | Jun 11 8:24 PM | TITUS BENJAMIN BALL | Proposed Sale | 169 | $257.20 | $43.5K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Oct 13, 2026 | Oct 15 9:08 PM | Xiaodong WangDirector, Other | Option Exercise | 403,351 | — | 403,364(D) | View → |
| Sep 28, 2026 | Sep 30 9:11 PM | Xiaodong WangDirector, Other | Option Exercise | 403,364 | — | 806,715(D) | View → |
| Sep 8, 2026 | Sep 10 8:49 PM | Xiaodong WangDirector, Other | Option Exercise | 403,351 | — | 1,210,079(D) | View → |
| Aug 11, 2026 | Aug 14 12:54 AM | Chan Henry LeeSVP, General Counsel | Option Exercise | 34,658 | — | 88,582(D) | View → |
| Jul 22, 2026 | Jul 24 8:51 PM | Chan Henry LeeSVP, General Counsel | Option Exercise | 21,697 | — | 98,930(D) | View → |
| Jul 20, 2026 | Jul 22 9:03 PM | John OylerDirector, Chief Executive Officer | Option Exercise | 441,870 | — | 0(D) | View → |
| Jul 17, 2026 | Jul 17 9:36 PM | John OylerDirector, Chief Executive Officer | Option Exercise | 840,164 | — | 441,870(D) | View → |
| Jul 16, 2026 | Jul 17 9:31 PM | John OylerDirector, Chief Executive Officer | Option Exercise | 2,165,761 | — | 1,282,034(D) | View → |
| Jul 15, 2026 | Jul 17 9:31 PM | John OylerDirector, Chief Executive Officer | Option Exercise | 1,515,241 | — | 1,254,513(D) | View → |
| Jul 14, 2026 | Jul 15 1:26 AM | John OylerDirector, Chief Executive Officer | Option Exercise | 1,736,800 | — | 462,866(D) | View → |
| Jul 13, 2026 | Jul 15 1:25 AM | John OylerDirector, Chief Executive Officer | Option Exercise | 630,760 | — | 1,264,666(D) | View → |
| Jul 10, 2026 | Jul 15 1:25 AM | John OylerDirector, Chief Executive Officer | Option Exercise | 152,074 | — | 1,895,426(D) | View → |
| Jul 8, 2026 | Jul 10 8:44 PM | Chan Henry LeeSVP, General Counsel | Option Exercise | 8,632 | — | 105,300(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Lai WangPresident, Global Head of R&D | Grant/Award | 229,775 | — | 229,775(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Aaron RosenbergChief Financial Officer | Grant/Award | 137,865 | — | 137,865(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Xiaobin WuPresident and COO | Grant/Award | 229,775 | — | 229,775(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Chan Henry LeeSVP, General Counsel | Grant/Award | 87,308 | — | 87,308(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | John OylerDirector, Chief Executive Officer | Grant/Award | 344,669 | — | 344,669(D) | View → |
| Jun 11, 2026 | Jun 15 9:54 PM | Xiaodong WangDirector, Other | Grant/Award | 193,492 | — | 193,492(D) | View → |
| May 13, 2026 | May 15 8:39 PM | Chan Henry LeeSVP, General Counsel | Option Exercise | 4,316 | — | 107,848(D) | View → |
Page 1 of 2
Next →